Vertex, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a VERX research report →
Range $12 – $21
Price Chart
About the company
Vertex, Inc. specializes in delivering advanced tax technology solutions to corporations across various sectors, including retail, communication, leasing, and manufacturing. These services are provided to clients both within the United States and globally.
- CEO
- Christopher David Young
- IPO
- 2020
- Employees
- 2,000
- HQ
- King of Prussia, PA, US
Get TickerSpark's AI analysis on VERX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $1.99B
- P/E
- 401.31
- Fwd P/E
- 14.98
- PEG
- -0.78
- P/S
- 2.53
- P/B
- 8.22
- EV/EBITDA
- 61.85
- Div Yield
- 0.00%
- Gross Margin
- 62.05%
- Op Margin
- -0.18%
- Net Margin
- 0.45%
- ROE
- 1.41%
- ROIC
- -0.02%
Latest fiscal year · YoY change
- Revenue
- $748.44M+12.2%
- Gross Profit
- $454.51M+6.7%
- Op Income
- $-7,846,000
- Net Income
- $7.21M+113.7%
- EPS
- $0.05+114.7%
- OCF Growth
- +0.4%
- FCF Growth
- -38.8%
- 52W High
- $26.54
- 52W Low
- $10.21
- 50D MA
- $12.68
- 200D MA
- $13.91
- Beta
- 0.82
- RSI (14)
- 50
- Avg Volume
- 1.89M
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Vertex posted a solid Q2 with revenue at the high end of guidance, strong EBITDA upside, and stable retention, while cloud conversion slowed and the company is leaning harder into e-invoicing and AI.· August 3, 2026
- Q2 revenue grew 10.5% year over year to $204 million, with adjusted EBITDA up 33% to $51 million and margin expanding to 25%.
- Customer durability remained solid: gross revenue retention was 95% and net revenue retention was 105% for the second straight quarter.
- Cloud conversions were slower than expected, so full-year cloud growth guidance was reduced to 18%, but management said this is mainly timing, not customer loss.
- E-invoicing showed stronger momentum, especially in Europe, with multiple 6-figure enterprise wins and early signs of cross-sell plus new-logo demand.
- AI adoption inside the company is rising quickly, but management said AI-attributable revenue is not yet material and customer-facing monetization is still a 2027 story.
Vertex reported second-quarter revenue of $204 million, up 10.5% year over year, with subscription software revenue up 10.7%, services revenue up 9.4%, annual recurring revenue up 10.5%, and cloud revenue up 17.9% (19.3% year to date). Adjusted EBITDA was $51 million, up 33% year over year, and adjusted EBITDA margin was 25%, more than 4 percentage points higher than last year. Non-GAAP gross margin increased 15 basis points year over year. Free cash flow was $2.7 million on a reported basis, or $13.2 million pro forma, with a 6.5% pro forma free cash flow margin and 26% conversion to adjusted EBITDA. For guidance, management expects Q3 revenue of $208 million to $211 million and adjusted EBITDA of $55 million to $57 million; full-year revenue guidance was narrowed to $825 million to $830 million and full-year adjusted EBITDA guidance was raised to $206 million to $210 million from $202 million to $208 million previously. Full-year cloud revenue growth is now expected to be 18%.
Chris Young framed the quarter as proof that Vertex’s core business is durable and that cost discipline is starting to create real operating leverage. He said the company still has work to do on expansion and new-logo growth, especially because cloud migrations have been slower than expected, but highlighted strong momentum in e-invoicing and early progress on AI. His tone was constructive and candid: upbeat about customer retention, compliance demand and leadership changes, but clear that growth execution still needs improvement.
John Schwab emphasized that the value creation plan is already showing up in margins and cash generation. He pointed to $204 million in revenue, $51 million in adjusted EBITDA, 25% adjusted EBITDA margin, a 15-basis-point gross margin improvement, and pro forma free cash flow of $13.2 million with 26% conversion. He also highlighted share repurchases of $26.5 million in the quarter at an average price of $13.17, bringing total repurchases under the $150 million program to $56.6 million and leaving $93.4 million remaining. On the outlook, he said the company expects a steady progression toward a high-20s EBITDA margin by the end of 2027 and a free cash flow conversion rate of about 70% exiting Q4 2027.
Analysts focused on three issues: whether slower cloud migration is temporary or structural, how much e-invoicing can offset that weakness, and when AI will become a customer-facing revenue driver. Management said the cloud shortfall is mainly timing and conversion delay, not customer loss, and that the year’s lower cloud guide reflects a slower-than-expected conversion ratio. On e-invoicing, they said mandate-driven demand is strong and they are beginning to see multi-country expansion and both cross-sell and new-logo wins. On AI, Chris Young said internal adoption is high and customer engagement is increasing, but commercial revenue remains early and the real monetization push is more likely in 2027 than 2026.
The bull case is that Vertex’s core tax and compliance franchise remains sticky, with 95% gross retention, 105% net retention and continued wins across SAP, Oracle and Microsoft ecosystems. Management also sees growing upside from e-invoicing mandates in France, Germany and beyond, plus meaningful internal efficiency gains from AI and a stronger leadership team to execute the next phase.
The main bear case is that growth is not yet accelerating where management wants it: expansion, new-logo performance and cloud migrations all remain slower than expected. Analysts also pressed on whether customers are prioritizing other IT and AI projects, and management acknowledged deal elongation and lower cloud conversion ratios, even if they believe the issue is timing rather than lost demand.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 89.1%
- Shares Outstanding
- 162.22M
- Float Shares
- 144.49M
of shares held by institutions
227 13F filers
Buy/sell ratio 8.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Vanguard Group Inc | 8.35M | ▼ 38.53K |
| Blackrock, Inc. | 6.24M | ▲ 576.78K |
| Vanguard Portfolio Management LLC | 4.98M | ▲ 203.45K |
| Morgan Stanley | 4.13M | ▼ 160.84K |
| Brown Advisory Inc | 3.55M | ▲ 1.74M |
| Vanguard Capital Management LLC | 3.17M | ▲ 58.43K |
| Tensile Capital Management LP | 2.90M | ▼ 500.00K |
| Jpmorgan Chase & Co | 2.53M | ▼ 843.13K |
| D. E. Shaw & Co., Inc. | 2.19M | ▲ 550.90K |
| William Blair Investment Management, LLC | 2.13M | ▲ 849.20K |
| State Street Corp | 2.06M | ▲ 149.94K |
| Ubs Group AG | 2.02M | ▼ 3.44M |
Held by 197 ETFs
Biggest fund positions in VERX by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 10, 26 | DeStefano David | other | 15,638 |
| Jun 10, 26 | Gayton Bradley M | other | 15,638 |
| Jun 10, 26 | Saunders Philip Seth | other | 15,638 |
| Jun 10, 26 | Radcliffe Amanda Westphal | other | 15,638 |
| Jun 10, 26 | Stamm John Richard | other | 15,638 |
| Jun 10, 26 | ANDERSEN ERIC C. | other | 15,638 |
| Jun 10, 26 | Thompson Stefanie Westphal | other | 15,638 |
| Jun 10, 26 | Mendola Mark J | other | 15,638 |
| May 28, 26 | DeStefano David | sell | 6,460 |
| Mar 9, 26 | ITEM SECOND IRR. TRUST FBO KYLE R. WESTPHAL u/a of JEFFREY R. WESTPHAL dated October 5, 2001 | buy | 10,000 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our VERX coverage
Recent articles, reports, and earnings notes.
No research on VERX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate VERX report →Axsome Therapeutics vs. Vertex Pharmaceuticals: Which Biotech Stock Is a Better Buy in 2026?
fool.com · Oct 1
Vertex Appoints DataRobot CEO Debanjan Saha to Board of Directors
globenewswire.com · Oct 1
2 Wall Street Analysts Think Vertex Pharmaceuticals Stock Can Soar Another 20% or More Over the Next 12 Months. Here's Why They're Right.
fool.com · Sep 29
Corient Private Wealth LP Purchases 153,840 Shares of Vertex, Inc. $VERX
defenseworld.net · Sep 25
CRISPR Therapeutics vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026?
fool.com · Sep 24
Vertex Posts Positive Phase II Data on Kidney Disease Drug
zacks.com · Sep 23
Vertex Touts Encouraging Data From 'Underappreciated' Kidney Drug
benzinga.com · Sep 22
Vertex Announces Positive Results From Phase 2b AMPLIFIED Study of Inaxaplin in Additional Populations of People With APOL1-Mediated Kidney Disease (AMKD) and Completion of Enrollment in the Phase 2/3 AMPLITUDE Trial
businesswire.com · Sep 22
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.